Human pluripotent stem cell culture passage dissociation reagent and application thereof

By adding non-enzymatic components such as arginine hydrochloride and lysine hydrochloride to the sodium ethylenediaminetetraacetate solution, the passage dissociation reagent for human pluripotent stem cells was optimized, solving the problems of long dissociation time and low efficiency in the existing technology, and achieving a more efficient and less damaging cell dissociation effect.

CN121022757AInactive Publication Date: 2025-11-28GENETIMES EXCELL TECH INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202511564774.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-10-30
Publication Date
2025-11-28
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Among the existing methods for passage and dissociation of human pluripotent stem cells (hPSCs), enzyme-based dissociation reagents have the disadvantages of long dissociation time and low efficiency, which cannot meet the needs of single-cell passage under special circumstances, and can also cause certain damage to cells.

Method used

A dissociation reagent containing non-enzymatic components such as arginine hydrochloride, lysine hydrochloride, sodium aspartate, and PEG8000 was used to optimize the sodium ethylenediaminetetraacetic acid solution. By chelating calcium and magnesium ions in the extracellular matrix, the solution reduced cell surface tension, promoted cell dissociation, and reduced damage.

Benefits of technology

It improves dissociation efficiency, shortens dissociation time, maintains high cell viability and quality, reduces cell damage, and meets the needs of single-cell passage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121022757A_ABST
    Figure CN121022757A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of cell culture, in particular to a human pluripotent stem cell culture passage dissociation reagent and application thereof. On the basis that sodium ethylene diamine tetracetate is commonly used as a key component of a cell dissociation reagent, a formula is optimized, and the following components are added: amino acid, a surfactant PEG (polyethylene glycol) and glucose, specifically arginine hydrochloride, lysine hydrochloride, sodium aspartate, PEG8000 and glucose. The added components are high in solubility and stable in property, the optimized dissociation reagent is easy and convenient to prepare, the implementation feasibility of the technical scheme is high, low damage to cells is guaranteed in the dissociation process, the cell viability is better maintained, and the quality of cells after passage is improved.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present application relates to the technical field of cell culture, in particular to a human pluripotent stem cell culture passage dissociation reagent and application thereof. BACKGROUND

[0002] Human pluripotent stem cells (hPSC) mainly include human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC), which are widely used in basic research, drug screening, cell and gene therapy and other directions, especially in cell and gene therapy direction, hPSC has broad market prospect and application space because of its potential for multi-directional differentiation and can differentiate into various "shelf type" cells for cell therapy. hPSC in vitro maintenance culture system is the basis of its application, hPSC culture has developed from serum-containing, feeder cell-containing adherent culture to serum-free, feeder cell-free culture system, and the passage dissociation of hPSC maintenance culture has also developed from traditional mechanical dissociation method to biological enzyme and chemical reagent dissociation method. The passage of hPSC culture can be divided into single cell passage and mass passage according to the specific state of the dissociated cells, and the dissociation reagent for single cell passage is usually biological enzyme solution, while the dissociation reagent for mass passage is usually a solution containing metal ion chelating agent. hPSC needs to be maintained in vitro to ensure high quality of cells, and studies have shown that enzyme dissociation for single cell passage has a certain degree of damage to hPSC, and currently more chemical dissociation reagents without enzymes are used in the application end. As a common metal ion chelating agent, sodium salt of ethylenediaminetetraacetic acid (EDTA-4Na) is often used as the main component of enzyme-free dissociation reagent due to its high cost performance, and is widely used in the passage of hPSC culture. Although more researchers currently prepare or purchase sodium salt of ethylenediaminetetraacetic acid solution for hPSC passage dissociation, its disadvantages are also obvious: long dissociation time, low efficiency, and cannot meet the needs of single cell passage in special cases. SUMMARY

[0003] In order to solve the technical problems mentioned in the background art, the present application provides a human pluripotent stem cell culture passage dissociation reagent and application thereof.

[0004] The purpose of the present application is to provide a human pluripotent stem cell culture passage dissociation reagent and application thereof, which uses a variety of non-enzyme components to promote cell dissociation, reduces hPSC damage while improving dissociation efficiency, and ensures better cell viability and higher cell quality during cell culture.

[0005] A human pluripotent stem cell culture passaging dissociation reagent is composed of the following components, specifically: arginine hydrochloride 1.1 g / L, lysine hydrochloride 0.9 g / L, sodium aspartate 0.8 g / L, glucose 1.0 g / L, PEG 40.0 g / L, EDTA-4Na 0.2-1.0 g / L, potassium chloride 0.2 g / L, sodium chloride 8.0 g / L, potassium dihydrogen phosphate 0.2 g / L, and disodium hydrogen phosphate 2.2 g / L.

[0006] Preferably, the EDTA-4Na is 0.2 g / L.

[0007] Preferably, the PEG is PEG8000.

[0008] Preferably, the human pluripotent stem cell is a human induced pluripotent stem cell.

[0009] The application of a human pluripotent stem cell culture passaging dissociation reagent includes the human pluripotent stem cell culture passaging dissociation reagent described in any of the preceding embodiments, and is used for the culture passaging dissociation of human pluripotent stem cells.

[0010] To achieve the above-mentioned purpose, the human pluripotent stem cell (hPSC) culture passaging dissociation reagent of the present application has the technical scheme that: on the basis of the commonly used sodium salt of ethylenediaminetetraacetic acid as the key component of the cell dissociation reagent, the formula is optimized and the following components are added: amino acids, a surfactant PEG, and glucose, specifically including: arginine hydrochloride, lysine hydrochloride, sodium aspartate, PEG8000, and glucose. Each added component has high solubility and stable properties, the optimized dissociation reagent is simple and convenient to prepare, and the technical scheme is highly feasible to implement.

[0011] In a preferred embodiment of the present application, one of the combination schemes is: arginine hydrochloride 0.2-2.0 g / L, lysine hydrochloride 0.2-2.0 g / L, sodium aspartate 0.2-2.0 g / L, glucose 0.5-2.0 g / L, PEG8000 5.0-50.0 g / L, EDTA-4Na 0.1-1.0 g / L, potassium chloride 0.2 g / L, sodium chloride 8.0 g / L, potassium dihydrogen phosphate 0.2 g / L, disodium hydrogen phosphate 2.2 g / L.

[0012] Preferably, in one preferred embodiment of the present application, one of the combination schemes is: arginine hydrochloride 1.1 g / L, lysine hydrochloride 0.9 g / L, sodium aspartate 0.8 g / L, glucose 1.0 g / L, PEG8000 40.0 g / L, EDTA-4Na 0.2 g / L, potassium chloride 0.2 g / L, sodium chloride 8.0 g / L, potassium dihydrogen phosphate 0.2 g / L, disodium hydrogen phosphate heptahydrate 2.2 g / L.

[0013] To achieve the above-mentioned purposes, the technical scheme adopted by the present application is: adopting human pluripotent stem cell (hPSC) continuous culture passage dissociation, compared with the control group, the dissociation reagent of the experimental group adding arginine hydrochloride, PEG8000 and other components has shorter required dissociation time, higher efficiency, and at the same time maintains higher cell viability and quality.

[0014] The beneficial effects of the present application mainly lie in that the present application proposes a dissociation reagent for improving the passage dissociation efficiency of human pluripotent stem cells (hPSCs). In the process of in vitro maintenance culture of hPSCs, cell passage dissociation is a necessary operation for cell expansion and stable maintenance. Cell dissociation requires chelating agents (EDTA-4Na), certain key amino acids (arginine hydrochloride), surfactant PEG8000 and other substances to destroy the intercellular matrix and reduce the cell surface tension, so that the cells are detached and dispersed from the culture plate (dish), thereby harvesting the cells. At the same time, the dissociation process ensures low damage to the cells, so that the cell viability is maintained better and the quality of the cells after passage is maintained.

[0015] The key technologies are: ① EDTA-4Na chelates calcium ions and magnesium ions in the extracellular matrix, thereby destroying the adhesion between cells and the matrix, and making the cells dissociate from the culture matrix; ② arginine hydrochloride and lysine hydrochloride, sodium aspartate synergistically promote cell contraction, increase shear force, and enhance dissociation effect; ③ PEG8000 reduces cell surface tension and reduces intercellular adhesion, helping cells to dissociate. Amino acids are nutrients for cell culture, EDTA-4Na and PEG8000 are stable in nature, and trace residues of the dissociation reagent have almost no harm to subsequent cell culture and do not bring other risks.

[0016] The mechanism of action of the present application is: in the sodium salt of ethylenediaminetetraacetic acid solution, adding a certain amount of other non-enzymatic components that promote cell dissociation is a good choice, which can maintain low damage to hPSCs and at the same time improve the efficiency of hPSC passage dissociation. The guanidino group of arginine can chelate with Ca 2+ -Mg 2+The aromatic hydrocarbon synergism of ATP enzyme reduces the activity of the enzyme, causing cell contraction, and achieving the effect of dissociating cells; aspartic acid sodium salt and lysine can increase shear force, synergize with arginine, enhance the dissociation effect, and cause less cell damage. Polyethylene glycol (PEG) can reduce the surface tension of cells, help cells dissociate from the culture medium, and reduce the adhesion between cells. Glucose can provide the energy required by cells, maintain the metabolic activity of cells, and reduce the stress response of cells during dissociation. BRIEF DESCRIPTION OF DRAWINGS

[0017] Figure 1 Flow cytometry detection chart of hiPSC markers OCT4 and TRA1-60 of the control group; Figure 2 Flow cytometry detection chart of hiPSC markers OCT4 and TRA1-60 of Example 1; Figure 3 Flow cytometry detection chart of hiPSC markers OCT4 and TRA1-60 of Example 2; Figure 4 Flow cytometry detection chart of hiPSC markers OCT4 and TRA1-60 of Example 3; Figure 5 Flow cytometry detection chart of hiPSC markers OCT4 and TRA1-60 of Example 4; Figure 6 Flow cytometry detection chart of hiPSC markers OCT4 and TRA1-60 of Example 5; Figure 7 Flow cytometry detection chart of hiPSC markers OCT4 and TRA1-60 of Example 6; Figure 8 Flow cytometry detection chart of hiPSC markers OCT4 and TRA1-60 of Example 7. DETAILED DESCRIPTION

[0018] The technical solutions of the present application will be further described below in combination with specific embodiments. The technical solutions in the embodiments of the present application will be clearly and completely described below in combination with the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, rather than all the embodiments. Based on the embodiments in the present application, all other embodiments obtained by those skilled in the art without creative labor fall within the scope of protection of the present application.

[0019] The amino acid components and other reagents described in the following examples were purchased from Sigma; the commercial hPSC maintenance medium: mTeSR™ Plus (item number: 100-0276), purchased from STEMCELL Technology.

[0020] All the following examples, adopt the way of adherent culture passage, including the following steps: Prepare cell strain: human induced pluripotent stem cells (hiPSC), cultured in commercial hPSC maintenance medium, culture conditions: incubator: 37℃, 5% CO2; with a cell density of 1000 / cm 2 Carry out subculture, subculture once every five days, after three subcultures, the cell state is stable, and the cells are reserved; Further, the cells are inoculated in a 6-well plate containing 2 mL of commercial hPSC maintenance medium at a density of 1000 / cm 2 , and placed in an incubator for culture, and the fresh medium is replaced every two days; Further, the hiPSC is subcultured and dissociated on the 5th, 10th, 15th and 20th days of cell culture (cell passages are recorded as P1, P2, P3 and P4, respectively), and the dissociation steps are as follows: remove the cell culture medium, add different examples of dissociation reagent, the amount is 1 mL, record the time required for dissociation, the number of cells harvested and the viability of each example in each passage; after each dissociation, the cells are inoculated in a 6-well plate containing 2 mL of commercial hPSC maintenance medium at a density of 1000 / cm 2 , and placed in an incubator for culture, and the fresh medium is replaced every two days; Further, after 25 days of culture (cell passage is recorded as P5), the cells are harvested by adding different examples of dissociation reagent, and the time required for dissociation, the number of cells harvested and the viability of each example in each passage are recorded, and the collected cells are subjected to flow detection of hiPSC markers OCT4 and TRA1-60.

[0021] Example 1: Human pluripotent stem cell dissociation reagent 1 EDTA-4Na 1.0 g / L, potassium chloride 0.2 g / L, sodium chloride 8.0 g / L, potassium dihydrogen phosphate 0.2 g / L, disodium hydrogen phosphate heptahydrate 2.2 g / L; Example 2: Human pluripotent stem cell dissociation reagent 2 PEG 8000 40.0 g / L, EDTA-4Na 0.2 g / L, potassium chloride 0.2 g / L, sodium chloride 8.0 g / L, potassium dihydrogen phosphate 0.2 g / L, disodium hydrogen phosphate heptahydrate 2.2 g / L; Example 3: Human pluripotent stem cell dissociation reagent 3 PEG 8000 40.0 g / L, EDTA-4Na 1.0 g / L, potassium chloride 0.2 g / L, sodium chloride 8.0 g / L, potassium dihydrogen phosphate 0.2 g / L, disodium hydrogen phosphate heptahydrate 2.2 g / L; Example 4: Human pluripotent stem cell dissociation reagent 4 Glucose 1.0 g / L, PEG 8000 40.0 g / L, EDTA-4Na 0.2 g / L, Potassium chloride 0.2 g / L, Sodium chloride 8.0 g / L, Potassium phosphate monobasic 0.2 g / L, Disodium phosphate heptahydrate 2.2 g / L; Example 5: Human pluripotent stem cell dissociation reagent 5 Glucose 1.0 g / L, PEG 8000 40.0 g / L, EDTA-4Na 1.0 g / L, Potassium chloride 0.2 g / L, Sodium chloride 8.0 g / L, Potassium phosphate monobasic 0.2 g / L, Disodium phosphate heptahydrate 2.2 g / L; Example 6: Human pluripotent stem cell dissociation reagent 6 Glucose 1.0 g / L, PEG 8000 40.0 g / L, EDTA-4Na 0.2 g / L, Potassium chloride 0.2 g / L, Sodium chloride 8.0 g / L, Potassium phosphate monobasic 0.2 g / L, Disodium phosphate heptahydrate 2.2 g / L; Example 7: Human pluripotent stem cell dissociation reagent 7 Glucose 1.0 g / L, PEG 8000 40.0 g / L, EDTA-4Na 1.0 g / L, Potassium chloride 0.2 g / L, Sodium chloride 8.0 g / L, Potassium phosphate monobasic 0.2 g / L, Disodium phosphate heptahydrate 2.2 g / L; Control group: EDTA-4Na 0.2 g / L, Potassium chloride 0.2 g / L, Sodium chloride 8.0 g / L, Potassium phosphate monobasic 0.2 g / L, Disodium phosphate heptahydrate 2.2 g / L.

[0022] Experimental results and conclusions: Table 1

[0023] Table 1 is the cell dissociation time, the time required for cell passage dissociation in different examples, compared with the control group, the experimental group adding key amino acids (arginine hydrochloride, etc.), surfactant PEG8000, the cell dissociation time is shorter, saving time more than 30%.

[0024] Table 2

[0025] Table 2 is the dissociated cell viability in different embodiments, the experimental group adding key amino acids (arginine hydrochloride, etc.), surfactant PEG8000, the viability is better, and can maintain more than 95%.

[0026] Table 3

[0027] Table 3 is the average proliferation fold of dissociated cells in different embodiments, the cell proliferation fold = the number of dissociated harvested cells / the number of cell inoculation; the average proliferation fold is the average value of the cell proliferation fold of each generation (P1, P2, P3, P4, P5) in each embodiment, the experimental group adding key amino acids (arginine hydrochloride, etc.), surfactant PEG8000, the cell proliferation ability is almost the same as that of the control group.

[0028] Figures 1-8 For the control group and different embodiments, the expression of the markers OCT4 and TRA1-60 revealing the cell quality characteristics after continuous passage and dissociation culture of hiPSC, compared with the control group, the experimental group adding key amino acids (arginine hydrochloride, etc.), surfactant PEG8000, after continuous dissociation and passage, the cell marker expression ratio is higher, and the cell quality is more stable.

[0029] The above embodiments only express several embodiments of the present application, and the description is more specific and detailed, but it cannot be understood as the limitation of the scope of the present application. It should be noted that for ordinary skilled persons in the art, without departing from the concept of the present application, several modifications and improvements can be made, which belong to the protection scope of the present application. Therefore, the protection scope of the present application patent should be subject to the appended claims.

Claims

1. A reagent for the culture, passage, and dissociation of human pluripotent stem cells, characterized in that, It is composed of the following components: arginine hydrochloride 1.1 g / L, lysine hydrochloride 0.9 g / L, sodium aspartate 0.8 g / L, glucose 1.0 g / L, PEG80004 0.0 g / L, EDTA-4Na 0.2 g / L, potassium chloride 0.2 g / L, sodium chloride 8.0 g / L, potassium dihydrogen phosphate 0.2 g / L, and disodium hydrogen phosphate heptahydrate 2.2 g / L.

2. The human pluripotent stem cell culture passage dissociation reagent as described in claim 1, characterized in that, The human pluripotent stem cells mentioned are human induced pluripotent stem cells.

3. The application of a human pluripotent stem cell culture passage dissociation reagent, characterized in that, Includes a human pluripotent stem cell culture passage dissociation reagent as described in any one of claims 1 to 2, used for the culture, passage, and dissociation of human pluripotent stem cells.

Citation Information

Patent Citations

  • Establishment method and application of clinical-grade neural stem cell line

    CN103451153A

  • Non-enzymatic dissociation liquid for separating adherent cells and preparation method of non-enzymatic dissociation liquid

    CN113088486A

  • Cell stripping liquid, cell stripping method and cell preservation method

    CN118159642A

  • Cell aggregation inhibitor, cell aggregation inhibition method, cell dispersion method, and cell analysis method

    JP2020048446A